Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Relay Therapeutics | RLAY | Nov 21, 2024 | 4.64 | -0.43 |
Reliance | RS | Nov 21, 2024 | 316.43 | +0.93 |
Reliance Global | RELI | Nov 21, 2024 | 1.30 | -5.80 |
Relmada Therapeutics | RLMD | Nov 21, 2024 | 2.75 | -3.51 |
RELX ADR | RELX | Nov 21, 2024 | 45.76 | +1.44 |
Remitly Global | RELY | Nov 21, 2024 | 20.68 | +1.08 |
Renaissance Ipo ETF | IPO | Nov 21, 2024 | 45.56 | +2.04 |
RenaissanceRe | RNR | Nov 21, 2024 | 264.64 | +0.13 |
RenaissanceRe G Pref | RNR-G | Nov 21, 2024 | 18.09 | +0.72 |
RenaissanceRe Holding F Pref | RNR-F | Nov 21, 2024 | 24.43 | +0.45 |
Renalytix ADR | RNLX | Nov 21, 2024 | 0.20 | 0.00 |
Renasant | RNST | Nov 21, 2024 | 37.30 | +2.59 |
ReNew Energy Global A Shares | RNW | Nov 21, 2024 | 5.63 | +2.55 |
Renn Fund | RCG | Nov 21, 2024 | 2.37 | +0.85 |
Renovaro Biosciences | RENB | Nov 21, 2024 | 0.50 | -0.60 |
RenovoRx | RNXT | Nov 21, 2024 | 1.21 | +1.69 |
Rent The Runway A | RENT | Nov 21, 2024 | 9.68 | +4.54 |
Rentokil Initial ADR | RTO | Nov 21, 2024 | 25.62 | -0.31 |
Repare Therapeutics | RPTX | Nov 21, 2024 | 2.97 | +4.58 |
Repay A | RPAY | Nov 21, 2024 | 8.03 | +0.12 |
Repligen | RGEN | Nov 21, 2024 | 141.76 | +2.06 |
Replimune Group | REPL | Nov 21, 2024 | 11.05 | -1.60 |
ReposiTrak | TRAK | Nov 21, 2024 | 22.67 | -4.59 |
Republic Bancorp A | RBCAA | Nov 21, 2024 | 76.01 | +1.56 |
Republic Services | RSG | Nov 21, 2024 | 214.06 | +0.68 |
Research Frontiers | REFR | Nov 21, 2024 | 1.95 | 0.00 |
Research Solutions | RSSS | Nov 21, 2024 | 3.08 | +4.76 |
Reservoir Media | RSVR | Nov 21, 2024 | 8.99 | +1.12 |
ReShape Lifesciences | RSLS | Nov 21, 2024 | 5.58 | +10.71 |
Resideo Technologies | REZI | Nov 21, 2024 | 26.37 | +0.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.